Keep away from concomitant use of tucatinib with CYP3A substrates, wherever negligible focus alterations could cause significant or everyday living-threatening toxicities. If unavoidable, cut down CYP3A substrate dose In keeping with products labeling.Con el fin de protegerlos de una intoxicación, siempre use tapaderas de seguridad e inmediatament